| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IL-1RL1 | HOT IL1-H5229 | Human IL-1RL1 / ST2 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $355.00 200ug | |
| IL-1RL1 | HOTAvitag IL1-H82E9 | Biotinylated Human IL-1RL1 / ST2 Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| IL-1RL1 | Human IL-1RL1 / ST2 Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $335.00 200ug | ||
| IL-1RL1 | HOT IL1-M5259 | Mouse IL-1RL1 / ST2 Protein, Fc Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $360.00 200ug | |
| IL-1RL1 | Cynomolgus IL-1RL1 / ST2 Protein, His Tag, low endotoxin (MALS & SPR verified) | Cynomolgus | HEK293 | MALSSDS-PAGE | $360.00 200ug | |||
| IL-1RL1 | Avitag IL1-H82F8 | Biotinylated Human IL-1RL1 / ST2 Protein, Fc,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Astegolimab | AMG-282; RG-6149; RO-7187807 | Phase 3 Clinical | Amgen Inc, F. Hoffmann-La Roche Ltd | Coronavirus Disease 2019 (COVID-19); Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive | Details |
| AK-139 | AK139; AK-139 | Phase 2 Clinical | Kangfang Biotechnology (Cayman) Co Ltd | Asthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Chronic Urticaria; Dermatitis, Atopic; Hypersensitivity; Prurigo Nodularis; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal | Details |
| TQC-2938 | TQC2938; TQC-2938 | Phase 2 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Asthma; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Seasonal | Details |
| Recombinant humanized anti-ST2 monoclonal antibody | 9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Asthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive | Details |
| NEROFE | Phase 1 Clinical | Immune System Key Ltd | Neoplasms; Solid tumours | Details |